Publications and communications of Vincenzo Castronovo

Paul, C., Tang, R., Longobardi, C., Lattanzio, R., Eguether, T., Turali, H., Bremond, J., Maurizy, C., Gabola, M., Poupeau, S., Turtoi, A., Denicolai, E., Cufaro, M. C., Svrcek, M., Seksik, P., Castronovo, V., Delvenne, P., de Laurenzi, V., Da Costa, Q., ... Hahne, M. (06 December 2022). Loss of primary cilia promotes inflammation and carcinogenesis. EMBO Reports, 23 (12), 55687. doi:10.15252/embr.202255687

Rademaker, G.* , Boumahd, Y.* , Peiffer, R., Anania, S., Wissocq, T., Liégeois, M., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., De Tullio, P., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (July 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biology, 53, 102324. doi:10.1016/j.redox.2022.102324
* These authors have contributed equally to this work.

Rademaker, G., Costanza, B., Pyr Dit Ruys, S., Peiffer, R., Agirman, F., Maloujahmoum, N., Vertommen, D., Turtoi, A., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2022). Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination. Oncogenesis, 11, 42. doi:10.1038/s41389-022-00416-4
* These authors have contributed equally to this work.

Anania, S., Peiffer, R., Rademaker, G., Hego, A., Thiry, M., Deldicque, L., Francaux, M., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (21 June 2020). Myoferlin is a yet unknown interactor of the mitochondrial dynamics’ machinery in pancreas cancer cells. Cancers, 12 (6), 1643. doi:10.3390/cancers12061643

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012

Anania, S., Rademaker, G., Peiffer, R., Hego, A., Deldicque, L., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (February 2020). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. BACR Annual Meeting 2020 - Cancer metastases: from bedside to bench, Brussels, Belgium.

Anania, S., Rademaker, G., Bellahcene, A., Castronovo, V., & Peulen, O. (December 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of Pancreatic Ductal Adenocarcinoma [Poster presentation]. Second CIRM Scientific Day, Liège, Belgium.

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (26 November 2019). Myoferlin depletion induces DNA damage response and p53- dependent cell cycle arrest and apoptosis in colon cancer [Poster presentation]. Metabolism in Cancer and Stromal Cells (2nd edition), Leuven, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (23 October 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity Through the Control of Oxidative Phosphorylation [Poster presentation]. Pancreatic Cancer Symposium, Toulouse, France.

Anania, S., Rademaker, G., Wissocq, T., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of PDAC [Poster presentation]. PANCREATIC CANCER SYMPOSIUM, Toulouse, France.

Costanza, B., Rademaker, G., Turtoi, A., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration [Poster presentation]. Pancreatic Cancer Symposium 2019, Toulouse, France.

Anania, S., Rademaker, G., Wissocq, T., Bellahcene, A., Castronovo, V., & Peulen, O. (06 September 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. EDT Cancerology 2019, Bruxelles, Belgium.

Peulen, O., Rademaker, G., Anania, S., Turtoi, A., Bellahcene, A., & Castronovo, V. (August 2019). Ferlin overview: from membrane to cancer biology. Cells, 8, 954. doi:10.3390/cells8090954

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (13 June 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity Through the Control of Oxidative Phosphorylation [Poster presentation]. Belgian Society for Cell and Developmental Biology - Spring Meeting, Liège, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Di Valentin, E., Goval, J.-J., Bellahcene, A., Castronovo, V., & Peulen, O. (June 2019). Myoferlin contributes to the metastatic phenotype of pancreatic cancer cells by enhancing their migratory capacity through the control of oxidative phosphorylation. Cancers, 11 (6). doi:10.3390/cancers11060853

Costanza, B., Rademaker, G., Tiamiou, A., De Tullio, P., Leenders, J., Blomme, A., Bellier, J., Bianchi, E., Turtoi, A., Delvenne, P., Bellahcene, A., Peulen, O.* , & Castronovo, V.*. (2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International Journal of Cancer. doi:10.1002/ijc.32247
* These authors have contributed equally to this work.

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Peiffer, R., Agirman, F., Maloujahmoum, N., Habraken, Y., Delvenne, P., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2019). Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis. doi:10.1038/s41389-019-0130-6
* These authors have contributed equally to this work.

Brohée, L., Peulen, O., Nusgens, B., Castronovo, V., Thiry, M., Colige, A., & Deroanne, C. (04 May 2018). Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression. Scientific Reports, 8 (1), 7050. doi:10.1038/s41598-018-25340-9

Hoge, A., Bernardy, F., Donneau, A.-F., Dardenne, N., Degée, S., TIMMERMANS, M., Nisolle, M., Guillaume, M., & Castronovo, V. (April 2018). Low omega-3 index values and monounsaturated fatty acid levels in early pregnancy: an analysis of maternal erythrocytes fatty acids. Lipids in Health and Disease, 17, 63. doi:10.1186/s12944-018-0716-6

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366

Umelo, I. A., Costanza, B., & Castronovo, V. (2018). Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies. Cancer and Metastasis Reviews. doi:10.1007/s10555-017-9710-0

Hendrick, E., Peixoto, P., Blomme, A., Polese, C., Matheus, N., Cimino, J., Frère, A., Mouithys-Mickalad, A., Serteyn, D., Bettendorff, L., Elmoualij, B., De Tullio, P., Eppe, G., Dequiedt, F., Castronovo, V., & Mottet, D. (2017). Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition. Oncogene. doi:10.1038/onc.2017.103

Costanza, B., Umelo, I., Bellier, J., Turtoi, A., & Castronovo, V. (2017). Stromal Modulators of TGF-β in Cancer. Journal of Clinical Medicine. doi:10.3390/jcm6010007

Nokin, M.-J., Durieux, F., Bellier, J., Peulen, O., Uchida, K., Spiegel, D. A., Cochrane, J. R., Hutton, C. A., Castronovo, V., & Bellahcene, A. (2017). Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death. Scientific Reports, 7 (1), 11722. doi:10.1038/s41598-017-12119-7

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375

Turtoi, A., Otaka, Y., Rokudai, S., Yokobori, T., Costanza, B., Oyama, T., Kuwano, H., DELWAIDE, J., DELVENNE, P., DETRY, O., Castronovo, V., & Nishiyama, M. (March 2016). Discovery of novel accessible proteins for therapeutic targeting of hepatocellular carcinoma. Acta Gastro-Enterologica Belgica, 79 (1), 13.

Blomme, A., Cusumano, P., Peulen, O., Bellahcene, A., Castronovo, V., & Turtoi, A. (2016). L'asporine : une nouvelle defense naturelle contre le cancer du sein. MS. Medecine Sciences, 32 (11), 1019-1022. doi:10.1051/medsci/20163211020

Costanza, B., Blomme, A., Bellahcene, A., Peulen, O., MUTIJIMA NZARAMBA, E., DELVENNE, P., De Pauw, E., DETRY, O., COIMBRA MARQUES, C., Castronovo, V., & Turtoi, A. (2016). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers. Acta Gastro-Enterologica Belgica, 79 (1), 11.

Fradet, A., Bouchet, M., Delliaux, C., Gervais, M., Kan, C., Benetollo, C., Pantano, F., Vargas, G., Bouazza, L., Croset, M., Bala, Y., Leroy, X., Rosol, T. J., Rieusset, J., Bellahcene, A., Castronovo, V., Aubin, J. E., Clezardin, P., Duterque-Coquillaud, M., & Bonnelye, E. (2016). Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone. Oncotarget, 7 (47), 77071-77086. doi:10.18632/oncotarget.12787

Quemener, C., Baud, J., Boye, K., Dubrac, A., Billottet, C., Soulet, F., Darlot, F., Dumartin, L., Sire, M., Grepin, R., Daubon, T., Rayne, F., Wodrich, H., Couvelard, A., Pineau, R., Schilling, M., Castronovo, V., Sue, S.-C., Clarke, K., ... Bikfalvi, A. (2016). Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer. Cancer Research, 76 (22), 6507-6519. doi:10.1158/0008-5472.CAN-15-2864

Costanza, B., Blomme, A., MUTIJIMA NZARAMBA, E., DELVENNE, P., DETRY, O., Castronovo, V., & Turtoi, A. (March 2015). Expel: a novel non-destructive method for mining soluble tumor biomarkers. Acta Gastro-Enterologica Belgica, 78 (1), 13.

Perez Palacios, A., Blomme, A., Boutry, S., Doumont, G., Sherer, F., Van Simaeys, G., Debois, D., JERUSALEM, G., COLLIGNON, J., DELVENNE, P., DETRY, O., De Pauw, E., Muller, R., Goldman, S., Castronovo, V., & Turtoi, A. (March 2015). Metabolomic, proteomic and preclinical imaging of patient-derived tumor xenografts for improving treatment of liver metastases patients. Acta Gastro-Enterologica Belgica, 78 (1), 134.

Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez-Palacios, A., Mouithys-Mickalad, A., LIFRANGE, E., Delvenne, P., Castronovo, V., & Turtoi, A. (31 January 2015). Myoferlin Regulates Endosomal Trafficking and Tunes Cancer Cell Metabolism [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER "A.B.E.C» ANNUAL MEETING 2015: TUMOR METABOLISM AND MITOCHONDRIA, Louvain, Belgium.

Fahmy, K., Peulen, O., Castronovo, V., Bellahcene, A., Turtoi, A., Thiry, M., Delvenne, P., PEIXOTO, P., Gonzalez, A., & ARAFA, M. (31 January 2015). Myoferlin: an indispensable component in VEGFA secretion by pancreas cancer cells [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER, Bruxelles, Belgium.

Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez Palacios, A., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (27 January 2015). Myoferlin regulates endosomal trafficking and tunes cancer cell metabolism [Poster presentation]. GIGA-DAY 2015: Current advances in medical genetics and genomics, Liège, Belgium.

Fahmy, K., Gonzalez, A., Arafad, M., Turtoi, A., Bellahcene, A., DELVENNE, P., Thiry, M., Castronovo, V., & Peulen, O. (27 January 2015). Myoferlin: an indispensable component in VEGR-A secretion by pancreatic cancer cell [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Smargiasso, N., Baiwir, D., De Pauw, E., De Tullio, P., Thiry, M., Peulen, O., Turtoi, A., Castronovo, V., & Bellahcene, A. (27 January 2015). Accumulation of methylglyoxal, a glycolysis by-product modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcene, A., BIANCHI, E., GOFFLOT, S., Drion, P., Trombino, G. E., Di Valentin, E., CUSUMANO, G., MAWEJA, S., JERUSALEM, G., Delvenne, P., LIFRANGE, E., Castronovo, V., & Turtoi, A. (2015). Asporin Is a Fibroblast-Derived TGF-beta1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Medicine, 12 (9), 1001871. doi:10.1371/journal.pmed.1001871

Mskhiladze, L., Chincharadze, D., Tits, M., Wauters, J.-N., Bellahcene, A., Castronovo, V., Mouithys-Mickalad, A., Franck, T., & Frederich, M. (2015). Identification of Cytotoxic and Antioxidant Compounds from Allium gramineum Flowers. International Journal of Pharmaceutical Sciences and Drug Research, 7, 78-82.

Turtoi, A., Blomme, A., & Castronovo, V. (2015). Intratumoral heterogeneity and consequences for targeted therapies. Bulletin du Cancer, 102 (1), 17-23. doi:10.1016/j.bulcan.2014.12.006

Castronovo, V., Blomme, A., Delvenne, P., DETRY, O., & Turtoi, A. (March 2014). TGF-B induced protein IG-H3 is essential for the growth of human liver metastases. Acta Gastro-Enterologica Belgica, 77 (1), 05.

Turtoi, A., Blomme, A., Debois, D., SOMJA, J., De Pauw, E., DETRY, O., & Castronovo, V. (March 2014). Organized proteomic heterogeneity in colorectal liver metastases and implications for therapies. Acta Gastro-Enterologica Belgica, 77 (1), 07.

Costanza, B., Blomme, A., Bellahcene, A., Hennequière, V., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (2014). Myoferlin is a Key Regulator of HER Receptor Family Function in Breast Cancer [Paper presentation]. EDT Annual Mini symposium 2014.

Suarez-Carmona, M., Hubert, P., Gonzalez, A., Duray, A., RONCARATI, P., Erpicum, C., Boniver, J., Castronovo, V., Noël, A., Saussez, S., Peulen, O., Delvenne, P., & Herfs, M. (2014). DeltaNp63 isoform-mediated beta-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma. Oncotarget, 5 (7), 1856-1868. doi:10.18632/oncotarget.1819

Tilli, T. M., Bellahcene, A., Castronovo, V., & Gimba, E. R. P. (2014). Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines. BMC Cancer, 14, 433. doi:10.1186/1471-2407-14-433

Turtoi, A.* , Blomme, A.* , BIANCHI, E., Maris, P., Vannozzi, R., Naccarato, A. G., DELVENNE, P., De Pauw, E., Bevilacqua, G., & Castronovo, V. (2014). Accessibilome of human glioblastoma: collagen-VI-alpha-1 is a new target and a marker of poor outcome. Journal of Proteome Research, 13 (12), 5660-5669. doi:10.1021/pr500657w
* These authors have contributed equally to this work.

Peulen, O.* , Gonzalez, A.* , Peixoto, P., Turtoi, A., Mottet, D., Delvenne, P., & Castronovo, V. (11 September 2013). The Anti-Tumor Effect of HDAC Inhibition in a Human Pancreas Cancer Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2. PLoS ONE, 8 (9), 75102. doi:10.1371/journal.pone.0075102
* These authors have contributed equally to this work.

Novo, C. L., Polese, C., Matheus, N., Decottignies, A., Londono-Vallejo, A., Castronovo, V., & Mottet, D. (September 2013). A new role for histone deacetylase 5 in the maintenance of long telomeres. FASEB Journal, 27. doi:10.1096/fj.12-224204

bournine, L., Bensalem, S., Wauters, J.-N., Iguer-Ouada, M., Maiza-Benabdesselam, F., Bedjou, F., Castronovo, V., Bellahcene, A., Tits, M., & Frederich, M. (2013). Identification and Quantification of the Main Active Anticancer Alkaloids from the Root of Glaucium flavum. International Journal of Molecular Sciences, 14, 23533-23544. doi:10.3390/ijms141223533

Calligaris, D., Longuespée, R., Debois, D., Asakawa, D., Turtoi, A., Castronovo, V., Noël, A., Bertrand, V., De Pauw-Gillet, M.-C., & De Pauw, E. (2013). Selected Protein Monitoring in Histological Sections by Targeted MALDI-FTICR in-source decay Imaging. Analytical Chemistry, 85 (4), 2117-26. doi:10.1021/ac302746t

Fradet, A., Sorel, H., Depalle, B., Serre, C. M., Farlay, D., Turtoi, A., Bellahcene, A., Follet, H., Castronovo, V., Clezardin, P., & Bonnelye, E. (2013). A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer. PLoS ONE, 8 (9), 75092. doi:10.1371/journal.pone.0075092

Lamour, V., Nokin, M.-J., Henry, A., Castronovo, V., & Bellahcene, A. (2013). Les proteines SIBLING - Outils moleculaires de la progression tumorale et de l'angiogenese. MS. Medecine Sciences, 29 (11), 1018-25. doi:10.1051/medsci/20132911019

Turtoi, A.* , Blomme, A.* , Bellahcene, A., Gilles, C., Hennequière, V., Peixoto, P., BIANCHI, E., Noël, A., De Pauw, E., LIFRANGE, E., Delvenne, P., & Castronovo, V. (2013). Myoferlin is a key regulator of EGFR activity in breast cancer. Cancer Research, 73, 5438-5448. doi:10.1158/0008-5472.CAN-13-1142
* These authors have contributed equally to this work.

Warnock, G., Turtoi, A., Blomme, A., Gonzalez, A., Bretin, F., Bahri, M. A., Lemaire, C., Seret, A., Castronovo, V., Luxen, A., & Plenevaux, A. (October 2012). In Ovo PET Imaging Of A Human Colorectal Carcinoma Model In Chicken Chorioallantoic Membrane [Poster presentation]. Annual Congress of the European Association of Nuclear Imaging, Milan, Italy.

Turtoi, A., Blomme, A., Delvaux, D., Dumont, B., SOMJA, J., Debois, D., DELVENNE, P., De Pauw, E., DE ROOVER, A., Honoré, P., DETRY, O., & Castronovo, V. (May 2012). INTRA-TUMORAL HETEROGENEITY AND RATIONAL SELECTION OF ANTIGENS FOR TARGETED THERAPY OF LIVER METASTASES. Acta Chirurgica Belgica, 112 (3), 89.FP53.

Dumont, B., Castronovo, V., Peulen, O., BLETARD, N., Clézardin, P., Delvenne, P., De Pauw, E., Turtoi, A., & Bellahcene, A. (2012). Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis. Journal of Proteome Research. doi:10.1021/pr201022n

Tilli, T. M., Mello, K. D., Ferreira, L. B., Matos, A. R., Accioly, M. T., Faria, P. A., Bellahcene, A., Castronovo, V., & Gimba, E. R. (2012). Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells. Prostate. doi:10.1002/pros.22523

Turtoi, A., & Castronovo, V. (2012). Isotopically labeled proteome as an internal standard for multiple reaction monitoring-based biomarker quantification. Expert Review of Proteomics, 9 (3), 245-8. doi:10.1586/epr.12.27

Turtoi, A., Mottet, D., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Colige, A., De Pauw, E., Bellahcene, A., & Castronovo, V. (2012). The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis. doi:10.1007/s10456-012-9279-8

Turtoi, A., Musmeci, D., Naccarato, A. G., Scatena, C., Ortenzi, V., Kiss, R., Murtas, D., Patsos, G., Mazzucchelli, G., De Pauw, E., Bevilacqua, G., & Castronovo, V. (2012). Sparc-like protein 1 is a new marker of human glioma progression. Journal of Proteome Research, 11 (10), 5011-21. doi:10.1021/pr3005698

Castronovo, V., Blomme, A., Dumont, B., & Turtoi, A. (2011). Development of Targeted Therapies for Liver Metastases: Is Heterogeneity a Major Issue? [Paper presentation]. Annual Meeting at Experimental Biology, Washington DC, United States.

Fradet, A., Sorel, H., Bouazza, L., Goehrig, D., Depalle, B., Bellahcene, A., Castronovo, V., Follet, H., Descotes, F., Aubin, J. E., Clezardin, P., & Bonnelye, E. (2011). Dual function of ERR alpha in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Research, 71 (17), 5728-38. doi:10.1158/0008-5472.CAN-11-1431

Kischel, P., Waltregny, D., Greffe, Y., Mazzucchelli, G., De Pauw, E., de Leval, L., & Castronovo, V. (2011). Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma. Proteome Science, 9 (1), 63. doi:10.1186/1477-5956-9-63

NIZET, J.-L., Gonzalez, A., Peulen, O., & Castronovo, V. (2011). Transferts graisseux au niveau du sein: implications oncologiques. Revue Médicale de Liège, 66 (5-6), 362-6.

Castronovo, V., Wang, Y. H., Musmeci, D., Dumont, B., & Turtoi, A. (2010). Proteomic analysis of human pancreas cancers for the identification of targetable biomarkers [Paper presentation]. Federation of American Societies for Experimental Biology, Steamboat Springs, Colorado, United States.

Castronovo, V., Waltregny, D., Detry, O., Coimbra Marques, C., De Roover, A., Honore, P., De Pauw, E., & Turtoi, A. (October 2009). Le ciblage therapeutique: vers une guerre propre et efficace contre le cancer [Paper presentation]. Journée Synthèse 2009 CHU La recherche translationnelle au CHU de Liège, Liège, Belgium.

Castronovo, V. (May 2003). Dépistage et détection précoce des cancers : Pourquoi? Comment? Lesquels? Qui et où? A quel prix? Revue Médicale de Liège, 58 (5), 310-3.

Castronovo, V. (April 2003). Alimentation et cancer. Revue Médicale de Liège, 58 (4), 231-9.

Charlier, C., Bruyneel, E., Lechanteur, C., Bracke, M., Mareel, M., & Castronovo, V. (19 December 1996). Enhancement of Tamoxifen-Induced E-Cadherin Function by Ca2+ Channel Antagonists in Human Breast Cancer Mcf7/6 Cells. European Journal of Pharmacology, 317 (2-3), 413-6. doi:10.1016/S0014-2999(96)00816-3

Chariot, A., & Castronovo, V. (11 May 1996). Detection of Hoxa1 Expression in Human Breast Cancer. Biochemical and Biophysical Research Communications, 222 (2), 292-7. doi:10.1006/bbrc.1996.0737

Chariot, A., Castronovo, V., Le, P., Gillet, C., Sobel, M. E., & Gielen, J. (1996). Cloning and expression of a new HOXC6 transcript encoding a repressing protein. Biochemical Journal, 319, 91-97. doi:10.1042/bj3190091

Chariot, A., Moreau, L., Senterre, G., Sobel, M. E., & Castronovo, V. (13 October 1995). Retinoic Acid Induces Three Newly Cloned Hoxa1 Transcripts in Mcf7 Breast Cancer Cells. Biochemical and Biophysical Research Communications, 215 (2), 713-20. doi:10.1006/bbrc.1995.2522

Bellahcene, A., Merville, M.-P., Gielen Jacques, Lambotte, R., Simar, L., & Castronovo, V. (01 May 1994). La protéine P53, protectrice de l'intégrité du génome: rôle dans la genèse des cancers. Revue Médicale de Liège, 49 (5), 274-84.

Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., & Kasai, K. (1994). Galectins: a family of animal beta-galactoside-binding lectins. Cell, 76 (4), 597-8. doi:10.1016/0092-8674(94)90498-7

Colin, C., Lifrange, E., Genicot, F., Castronovo, V., & Lambotte, R. (November 1990). Le tamoxifene comme premier traitement du cancer du sein chez la femme âgée: un recul de 10 ans. Revue Médicale de Liège, 45 (11), 533-8.

Basson, C. T., Knowles, W. J., Bell, L., Albelda, S. M., Castronovo, V., Liotta, L. A., & Madri, J. A. (1990). Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events. Journal of Cell Biology, 110 (3), 789-801. doi:10.1083/jcb.110.3.789

Castronovo, V., Simar, L., & Geubelle, F. (15 October 1981). Infections respiratoires et pathologie de la clairance muco-ciliaire. Revue Médicale de Liège, 36 (20), 760-6.